Post Categories
Blog post not found!
mRNA: Great Expectations vs. Limited Applications
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…

mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
Will You Need a COVID-19 Vaccine Booster Shot?
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….

Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…

When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
COVID-19 Symptoms in the Vaccinated vs. Unvaccinated
Earlier this month, the United States reached a crucial milestone: Per the Centers for Disease Control and Prevention (CDC) website, 55 percent of the…

COVID-19 Symptoms in the Vaccinated vs. Unvaccinated
October 6, 2021
Earlier this month, the United States reached a crucial milestone: Per the Centers for Disease Control and Prevention (CDC) website, 55 percent of the…
How SARS-CoV-2 Spreads Infection So Efficiently | Part 3 – Invasion of the Variants
In the first two blogs of this three-part series on how SARS-CoV-2 spreads, QPS has covered how the SARS-CoV-2 spike protein can attach to…

How SARS-CoV-2 Spreads Infection So Efficiently | Part 3 – Invasion of the Variants
October 4, 2021
In the first two blogs of this three-part series on how SARS-CoV-2 spreads, QPS has covered how the SARS-CoV-2 spike protein can attach to…
Move Over AAV – Anelloviruses May Be Key to NextGen Gene Therapy
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes to transform gene therapy by using a new class of vector — anelloviruses…

Move Over AAV – Anelloviruses May Be Key to NextGen Gene Therapy
September 27, 2021
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes to transform gene therapy by using a new class of vector — anelloviruses…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…